Bill
A 1248
Prohibits the sale of xylazine above a certain weight
2025 Regular Session
Introduced by George Alvarez and 25 co-sponsors
Prohibits sale of xylazine in quantities above a specified weight to curb large-volume purchases and reduce drug diversion and health risks; affects sellers, vets, and buyers.
RECOMMITTED TO CONSUMER PROTECTION